{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:35:52Z","timestamp":1761744952934},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer is one of the most common malignancies. Imaging tools play an important role throughout the entire process of the disease. The scenario, however, is going to change. Thanks to a higher sensitivity and specificity, the use of the prostate-specific membrane antigen (PSMA) PET is of increasing importance, particularly at the time of diagnosis and in case of biochemical recurrence. Nevertheless, previous reports have described false-positive findings, as tracer-avid physiological findings or benign processes, potential pitfalls for interpretation of <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT. Here we report a case of PSMA uptake in a histologically proven fibrous dysplasia.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002546","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T14:11:29Z","timestamp":1554127889000},"page":"e396-e397","source":"Crossref","is-referenced-by-count":13,"title":["68Ga-PSMA Uptake in Fibrous Dysplasia"],"prefix":"10.1097","volume":"44","author":[{"given":"Maria Lucia","family":"Reale","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Buttigliero","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tucci","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giardino","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Poti","sequence":"additional","affiliation":[{"name":"Unit of Nuclear Medicine, Aosta Regional Hospital, Aosta, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00259-017-3712-6","article-title":"Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET\/MRI","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/RLU.0000000000001672","article-title":"Evaluation of practical interpretation hurdles in 68Ga-PSMA PET\/CT in 55 patients: physiological tracer distribution and incidental tracer uptake","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","year":"2008","journal-title":"Clin Radiol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ucl.2018.03.016","article-title":"Advances in urologic imaging: prostate-specific membrane antigen ligand PET imaging","volume":"45","year":"2018","journal-title":"Urol Clin North Am"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","year":"2018","journal-title":"Radiographics"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","article-title":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20230925","first-page":"1085","article-title":"68Ga-PSMA PET\/CT in prostate cancer patients\u2014normal variants and pitfalls","volume":"58","year":"2017","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201906000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:11:09Z","timestamp":1695618669000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201906000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002546","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}